Kenvue Q2: Skin Health & Beauty Net Sales Rise 5.1%

Kenvue Inc.‘s fiscal second quarter net sales increased 3.0% and organic sales increased 1.6% at the corporate level.

“We delivered our third consecutive quarter of net and organic sales growth, with broad-based gains across every segment and region,” said Kirk Perry, CEO. “We also continued to drive operational efficiencies and increase strategic investment to fuel sustained momentum. Amidst a dynamic consumer and macro environment, our first-half 2026 results met or exceeded our expectations across key metrics, underscoring the strength and resilience of our people, brands, and new strategic plans.”

Perry said Kenvue’s “transformation” remained  “firmly on track” and that the company is focused on “disciplined execution and continued business improvement” as it works toward the planned merger with Kimberly-Clark in Q4.

Kenvue said the second quarter net sales increased compared to the prior year period reflected organic sales growth of 1.6% and a foreign currency benefit of 1.4%. Organic sales growth was driven by favorable value realization of 0.9% and volume growth of 0.7%, according to the company.

Skin Health & Beauty Business

Second quarter 2026 net sales in Kenvue’s skin health and beauty business increased 5.1% vs the prior year period, reflecting organic sales growth of 3.7% and a foreign currency benefit of 1.4%. Organic sales growth was driven by favorable value realization of 2.7% and a volume increase of 1.0%, as organic sales grew vs the prior year period across every region, largely driven by hair care and face care.

Strong e-commerce momentum, focused commercial execution and recent innovations, such as the OGX Pro Growth + Peptide and Neutrogena Ultra Sheer Sun, contributed to this strong performance globally, said Kenvue.

In the US, Kenvue said the company’s brand building actions behind Neutrogena helped improve household penetration for the third consecutive quarter, with gains across all generational cohorts.

Essential Health Business

Second quarter 2026 net sales increased 2.3% vs the prior year period, reflecting organic sales growth of 1.1% and a foreign currency benefit of 1.2%. Organic sales growth was driven by a volume increase of 1.9%, partially offset by unfavorable value realization of 0.8%. Organic sales grew vs the prior year period in the Asia Pacific, Latin America, and North America regions, with wound care and baby care need states fueling growth and more than offsetting a decline in oral care.

Strong momentum in the e-commerce channel, distribution gains in the US, as well as targeted activation behind innovations including Band-Aid Pro Heal 5 Day Protect in North America, the global restage of Listerine and the rollout of Listerine On-The-Go alcohol free mouthwash sachets.

Self Care Business

In self care, where Kenvue’s Tylenol and other OTC brands reside, Q2 2026 net sales increased 2.2% reflecting organic sales growth of 0.6% and a foreign currency benefit of 1.6%.